story of the week
Rucaparib in Metastatic Castration-Resistant Prostate Cancer With BRCA1/2 Alteration
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
J. Clin. Oncol 2020 Aug 14;[EPub Ahead of Print], W Abida, A Patnaik, D Campbell, J Shapiro, AH Bryce, R McDermott, B Sautois, NJ Vogelzang, RM Bambury, E Voog, J Zhang, JM Piulats, CJ Ryan, AS Merseburger, G Daugaard, A Heidenreich, K Fizazi, CS Higano, LE Krieger, CN Sternberg, SP Watkins, D Despain, AD Simmons, A Loehr, M Dowson, T Golsorkhi, S ChowdhuryFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.